Challenges in Ischemic Stroke Trials

This chapter explores the intricacies of conducting clinical trials for ischemic stroke treatments involving argatroban and eptifibatide. It examines the challenges of patient enrollment in acute situations, the trial's design and implementation, as well as the methods used to assess treatment outcomes and safety.